BlackRock Investment Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $868K | Sell |
2,595
-31
| -1% | -$10.4K | ﹤0.01% | 2766 |
|
|
2016
Q3 | $789K | Buy |
2,626
+299
| +13% | +$89.8K | ﹤0.01% | 2797 |
|
|
2016
Q2 | $403K | Buy |
2,327
+371
| +19% | +$64.3K | ﹤0.01% | 3144 |
|
|
2016
Q1 | $438K | Buy |
1,956
+30
| +2% | +$6.72K | ﹤0.01% | 2932 |
|
|
2015
Q4 | $1.17M | Buy |
1,926
+21
| +1% | +$12.7K | ﹤0.01% | 2476 |
|
|
2015
Q3 | $980K | Buy |
1,905
+298
| +19% | +$153K | ﹤0.01% | 2608 |
|
|
2015
Q2 | $703K | Buy |
1,607
+1,147
| +249% | +$502K | ﹤0.01% | 2991 |
|
|
2015
Q1 | $166K | Buy |
460
+15
| +3% | +$5.41K | ﹤0.01% | 3230 |
|
|
2014
Q4 | $160K | Hold |
445
| – | – | ﹤0.01% | 3269 |
|
|
2014
Q3 | $134K | Buy |
445
+2
| +0.5% | +$602 | ﹤0.01% | 3270 |
|
|
2014
Q2 | $271K | Buy |
443
+32
| +8% | +$19.6K | ﹤0.01% | 3193 |
|
|
2014
Q1 | $275K | Buy |
+411
| New | +$275K | ﹤0.01% | 3165 |
|